Status:
COMPLETED
Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C
Lead Sponsor:
Austrian Breast & Colorectal Cancer Study Group
Conditions:
Colon Cancer Stage III
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple combination, in terms of r...
Eligibility Criteria
Inclusion
- Patients with histologically verified, curatively operated colon carcinoma Stage III (R0, T1-4, N1-3, M0)
- Age: less than 80 years
- WHO Performace Status \> 2
- Adequate bone marrow reserve
- Informed consent
Exclusion
- Rectal cancer
- R1, R2, carcinosis peritonei
- Start of chemo- or chemo-immunotherapy \> 42 days postop; other adjuvant radiotherapy, chemotherapy or immunotherapy
- Serious concomitant disease, in particular chronically inflammatory large intestine, cardiopathic disease, malignant second carcinoma
Key Trial Info
Start Date :
October 1 1990
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
598 Patients enrolled
Trial Details
Trial ID
NCT00309530
Start Date
October 1 1990
Last Update
April 3 2006
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Guessing
Güssing, Burgenland, Austria, 7540
2
Hospital Oberpullendorf
Oberpullendorf, Burgenland, Austria, 7350
3
Hospital BHB St. Veit/Glan, Surgery
Saint Veit A. D. Glan, Carinthia, Austria, 9330
4
State Hospital Wolfsberg
Wolfsberg, Carinthia, Austria, 9400